Physician profile
Niharika Dixit
NPI 1912165440
$9,708.79
in general payments reported to CMS, 2019-2025
6 companies · $7,617 in 2025
The $7,617 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.75 · 2020: $1,963 · 2021: $84.08 · 2023: $19.81 · 2025: $7,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,380 · Food and Beverage: $237 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,380.00 |
| Food and Beverage | $236.81 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $7,380.00 | 2025 | Enhertu |
| E.R. Squibb & Sons, L.L.C. | $1,974.75 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $137.87 | 2025 | |
| Pfizer INC. | $116.36 | 2020-2025 | |
| Sandoz INC. | $80.00 | 2025 | |
| Merck Sharp & Dohme LLC | $19.81 | 2023 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niharika Dixit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.